Hims & Hers Health (NYSE:HIMS – Get Free Report) and Aspyra (OTCMKTS:APYI – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, valuation and profitability.
Volatility & Risk
Hims & Hers Health has a beta of 2.37, indicating that its share price is 137% more volatile than the S&P 500. Comparatively, Aspyra has a beta of -0.06, indicating that its share price is 106% less volatile than the S&P 500.
Earnings & Valuation
This table compares Hims & Hers Health and Aspyra”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Hims & Hers Health | $2.35 billion | 2.86 | $128.37 million | ($0.09) | -322.40 |
| Aspyra | N/A | N/A | N/A | N/A | N/A |
Hims & Hers Health has higher revenue and earnings than Aspyra.
Institutional and Insider Ownership
63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 23.9% of Aspyra shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current recommendations for Hims & Hers Health and Aspyra, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Hims & Hers Health | 2 | 11 | 4 | 0 | 2.12 |
| Aspyra | 0 | 0 | 0 | 0 | 0.00 |
Hims & Hers Health presently has a consensus price target of $28.70, suggesting a potential downside of 1.09%. Given Hims & Hers Health’s stronger consensus rating and higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than Aspyra.
Profitability
This table compares Hims & Hers Health and Aspyra’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Hims & Hers Health | -0.56% | 6.10% | 1.52% |
| Aspyra | N/A | N/A | N/A |
Summary
Hims & Hers Health beats Aspyra on 8 of the 10 factors compared between the two stocks.
About Hims & Hers Health
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
About Aspyra
Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.
Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.
-S.png){kind=small}
